Reports

Boyers, D, Imamura, M, Scott, N, Kumar, S, Tsehaye, M, Cruickshank, M, Manson, P, Ormerod, T, Brazzelli, M. Secukinumab for moderate-to-severe hidradenitis suppurativa [ID4039]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2023

Boyers, D, Scott, N, Cruickshank, M, Azharuddin, M, Hernandez, R, Ayansina, D, Manson, P, Virgilli, G, Azuara-Blanco, A, and Brazzelli, M. Netarsudil-latanoprost for previously treated open-angle glaucoma or ocular hypertension [ID1363] Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2023

Imamura, M, Getaneh, A, Cooper, D, Cruickshank, M, Manson, P, Shaukat, AA, Brazzelli, M, Scotland, G. Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 mutation after at least 1 therapy [ID6164]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2023

Boyers, D, Cruickshank, M, Scott, N, Jacobsen, E, Kumar, S, Imamura, M, Manson, P, Preston, G,Brazzelli, M. Axicabtagene for diffuse large B-cell lymphoma  [ID1684]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2022

Cruickshank, M, Cooper, D, Crozier, A, Robertson, C, Aucott, L, Manson, P, Ormerod, A, Scotland, G,Brazzelli, M. Deucravacitinib for treating moderate to severe plaque psoriasis [ID3859]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2022

Scotland, G, Cruickshank, M, Ayansina, D, Imamura, M, Kumar, S, Manson, P, Booth, C, Preston, G,Brazzelli, M. Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID3860]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2022

Vadiveloo, T, Scotland, G, Booth, C, Robertson, C, Cruickshank, M, Aucott, L, Kennedy, C, Manson, P, Preston, G,Brazzelli, M. Axicabtagene ciloleucel for non-Hodgkin lymphoma [ID1685]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2022

Vadiveloo, T, Scotland, G, Booth, C, Robertson, C, Cruickshank, M, Aucott, L, Kennedy, C, Manson, P, Preston, G,Brazzelli, M. Axicabtagene ciloleucel for treating relapsed or refractory low-grade non-Hodgkin lymphoma [ID1685]. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2022

Collaboration for Change. Collaboration for Change: promoting vaccine uptake. Manchester: We are Couch Ltd; 2021

Robertson, C, Booth, C, Ayansina, D, Hernandez, R, Manson, P, Herriot, R, Brazzelli, M,Scotland, G. Berotralstat for preventing acute attacks of hereditary angioedema [ID1624]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2021

Cruickshank, M, Boyers, D, Scott, N, Manson, P, Lumsden, C, Scotland, G,Brazzelli, M. Palforzia for treating peanut allergy [ID1282]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2021

Kennedy, C, Robertson, C, Cruickshank, M, Ayansina, D, Manson, P, Moroni, F, Brazzelli, M,Scotland, G. Teduglutide for treating short bowel syndrome [ID3937]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2021

Cruickshank, M, Kennedy, C, Aucott, L, Booth, C, Imamura, M, Vadiveloo, T, Manson, P, Preston, G, Scotland, G,Brazzelli, M. Venetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy [ID1564]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2021

Immamura, M, Kennedy, C, Aucott, L, Boyers, D, Cruickshank, M, Cooper, D, Manson, P, Ormerod, A,Brazzelli, M. Secukinumab for treating plaque psoriasis in children and young people [ID1669]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2021

Lone, N, Stewart, N, McPeake, J, Puxty, K, Kaye, C, Hall, R, Haddow, C, Paton, M, Donaldson, L, Wood, R,McAllister, D. Scottish Intensive Care Society Audit Group report on COVID-19: as at 31 January 2021. Edinburgh: 2021

Boyers, D, Jacobsen, E, Robertson, C, Imamura, M, Ayansina, D, Manson, P, Preston, G,Brazzelli, M. Chlormethine gel for teating mycosis fungoides-type cutaneous T-cell lymphoma. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2020

Clarkson, J, Ramsay, C, Aceves, M, Brazzelli, M, Colloc, T, Dave, M, Glenny, A-M, Goulão, B, Lamont, TJ, Richards, D, Robertson, C, Wilson, GJ,The, C-DSERWG. Recommendations for the re-opening of dental services: a rapid review of international sources. Cochrane Oral Health Group; 2020

Clarkson, JE, Ramsay, C, Aceves Martins, M, Brazzelli, M, Calvert, G, Colloc, T, Dave, M, Glenny, A-M, Goulao, B, Lamont, TJ, Richards, D, Riley, P, Robertson, C, Walsh, T, Wilson, GJ,Worthington, HV. Aerosol Generating Procedures and their Mitigation in International Dental Guidance Documents - A Rapid Review. Cochrane Oral Health Group; 2020

Hernandez, R, Robertson, C, Scott, N, Scotland, G, Booth, C, Manson, P, Broadhurst, P,Brazzelli, M. TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2020

Jacobsen, E, Boyers, D, Scott, NW, Imamura, M, Cruickshank, M, Manson, P, Preston, G,Brazzelli, M. Fostamatinib for treating chronic immune thrombocytopenia. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2020

Kopasker, D, Robertson, C, Aucott, L, Vadiveloo, T, Imamura, M, Manson, P, Walker, A, Urquhart, G, Brazzelli, M,Scotland, G. Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2020

Rzewuska, M. The discovery phase of implementing a deep learning classifier system for limbs fractures. AI in healthcare (Aberdeen University Artificial Intelligence society), Aberdeen, 4th February 2020.

Scotland, G, Kennedy, C, Imamura, M, Cooper, D, Robertson, C, Booth, C, Vadiveloo, T, Manson, P, Urquhart, G,Brazzelli, M. Darolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer [ID1443]. Evidence Review Group in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2020

Imamura, M, Cooper, D, Hernandez, R, Scotland, G, Ormerod, T,Brazzelli, M. Risankizumab for treating moderate to severe plaque psoriasis. Evidence Review Group report in support of NICE STA programme. London/Manchester: National Institute for Health and Care Excellence; 2019

Robertson, C, Fielding, S, Walker, A, Kopasker, D, Vadiveloo, T, Manson, P, Price, G, Brazzelli, M,Scotland, G. Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer Evidence Review Group report in support of NICE STA Programme. London/Manchester: National Institute for Health and Care Excellence; 2019

Rzewuska, M, Morgan, H, Skea, Z, Norrie , J,Campbell, M. InS:PIRE - Evaluation of the scaling up of a quality improvement initiative: abridged report. Aberdeen: University of Aberdeen; 2019

Avenell, A, Robertson, C, Skea, Z, Jacobsen, E, Boyers, D, Cooper, C, Aceves-Martins, M, Retat, L, Fraser, C, Aveyard, P, Stewart, F, MacLennan, G, Webber, L, Corbould, E, Xu, B, Jaccard, A, Boyle, B, Duncan, E, Shimonovich, M,de Bruin, M. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technology Assessment (Winchester, England) 2018;22(68).

Brazzelli, M, Hernandez, R, Sharma, P, Robertson, C, Shimonovich, M, MacLennan, G, Fraser, C, Jamieson, R,Vallabhaneni, SR. Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England) 2018;22(72):1-220.

Brazzelli M, Javanbakht M, Imamura M, Hudson J, Moloney E, Becker F, Wallace S, Omar MI, Shimonovich M, Maclennan G, Ternent L, Vale L, Montgomery I, Mackie P, Saraswat L, Monga A,  Craig D. The Effectiveness and cost-effectiveness of Surgical Treatments for womEn with stRess urinary incontinence (ESTER): An evidence synthesis, economic evaluation and discrete choice experiment. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2018

Cummins E, Aucott L, Robertson C, Fraser C, Johnston R, Lam T,  Brazzelli M. Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2018

Hernandez R, Cruickshank AM, Dimitrova M, Cooper D, Aucott L, Fraser C, Shimonovich M, Ormerod A, Scotland G,  Brazzelli M. Dupilumab for treating adults with moderate to severe atopic dermatitis. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2018

Boyers, D, Cruickshank, M, Jacobsen, E, Cooper, D, Fraser, C, Culligan, D,Scotland, G. Brentuximab vedotin for relapsed or refractory systemic anaplastic large cell lymphoma. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2017

Brazzelli, M, Hernandez, R, Sharma, P, Robertson, C, Shimonovich, M, MacLennan, G, Fraser, C, Jamieson, R,Vallabhaneni, S. The clinical and cost-effectiveness of protocols using contrast-enhanced ultrasound and/or colour duplex ultrasound in the long-term surveillance of endovascular abdominal aortic aneurysm repair: an evidence synthesis and economic evaluation. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2017

Brazzelli, M, Cummins, E, Fielding, S, Cruickshank, M, Fraser, C, Azuara-Blanco, A. Aflibercept for treating myopic choroidal neovascularisation. Fast track appraisal: cost comparison case. Evidence Review Group Report in support of NICE Fast Track Appraisal Programme. London: National Institute for Health and Care Excellence; 2017

Independent Review Group on Transvaginal Mesh Implants, Glazener, C. The Scottish Independent Review of the use, safety and efficacy of transvaginal mesh implants in the treatment of stress urinary incontinence and pelvic organ prolapse in women. . Final Report. Edinburgh: The Scottish Government; 2017

Scotland, G, Cruickshank, M, Jacobsen, E, Cooper, D, Fraser, C, Shimonovich, M, Marks, A,Brazzelli, M. Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis. Diagnostic assessment report in support of the NICE Diagnostic Assessment Programme. University of Aberdeen: Health Services Research Unit; 2017

Scotland, G, Kopasker, D, Scott, N, Cruickshank, M, Hernandez, R, Fraser, C, McLean, M, McKinlay, A,Brazzelli, M. Teduglutide for treating short bowel syndrome. Evidence Review Group report in support of NICE STA programme. London: National Institute for Health and Care Excellence; 2017

Brazzelli, M, Hawkins, N, McKeekin, N, Goulao, B, Cooper, D, Sharma, P, Fraser, C, Nicolson, M,Wu, O. Pembrolizumab after platinum chemotherapy for treating advanced, recurrent, PD-L1 positive, non-small cell lung cancer. . Evidence Review Group report in support of the NICE STA University of Aberdeen: Health Services Research Unit; 2016

Cummins, E, Culligan, D, Cooper, D, Fraser, C, Robertson, C,Ramsay, C, R. Ibrutinib for treating relapsed or refractory chronic lymphocytic leukaemia Evidence Review Group report in support of the NICE STA Programme. University of Aberdeen: Health Services Research Unit; 2016

Cummins, E, Ayansina, D, Sharma, P, Fraser, C, Shimonovich, M, McLean, M,Brazzelli, M. Eluxadoline for treating irritable bowel syndrome with diarrhoea. Evidence Review Group report in support of NICE STA programme. University of Aberdeen: Health Services Research Unit; 2016

Scotland, G, Hernandez, R, Robertson, C, Scott, N,Fraser, C. Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases (men who have not received docetaxel and for whom docetaxel is contraindicated or not suitable).

ERG critique of the company submission for re-consideration of current CDF technologies under the new proposed CDF criteria. University of Aberdeen: Health Services Research Unit; 2016

Scott, N, Cummins, E, Cruickshank, M, Fraser, C, Lois, N,Brazzelli, M. Aflibercept for treating visual impairment due to macular oedema secondary to branch vein occlusion: a single technology appraisal. . Evidence Review Group report in support of the NICE STA Programme. . University of Aberdeen: Health Services Research Unit; 2016

Cruickshank, M, Henderson, L, MacLennan, G, Fraser, C, Campbell, M, Blackwood, B, Gordon, A,Brazzelli, M. Alpha2-agonists for sedation of mechanically-ventilated adults in intensive care units: a systematic review. Technology Assessment Report submitted to the NIHR HTA Programme. University of Aberdeen: Health Services Research Unit; 2015

Cummins E, Scott N, Cruickshank M, Fraser C, Ormerod A, Brazzelli M.  Secukinumab for treating moderate to severe plaque psoriasis. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

Glazener, C, Breeman, S, Elders, A, Hemming, C, Cooper, K, Freeman, RF, Smith, A, Hagen, S, Montgomery, I, Kilonzo, M, Boyers, D, Maclennan, G, McDonald, A, McPherson, G,Norrie , J. Clinical and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study: results from the PROSPECT Study Final grant report submitted to the NIHR HTA programme. University of Aberdeen: Health Services Research Unit; 2015

Independent Review Group on Transvaginal Mesh Implants [Glazener, C]. The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women. Interim Report. Edinburgh: The Scottish Government; 2015

Robertson C, Lam T, Fielding S, Cummins E, Fraser C, Scotland G et al.  Enzalutamide for treating metastatic hormone-relapsed prostate cancer not previously treated with chemotherapy. Evidence Review Group report in support of the NICE STA Programme.  University of Aberdeen; Health Services Research Unit: 2015.

Scotland, G, Javanbakht, M, Scott, N, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Ezetimibe for treating primary (heterozygous-familial and non-familial) hypercholesterolaemia. . Evidence Review Group report in support of the NICE STA Programme. University pf Aberdeen: Health Services Research Unit; 2015

Scotland, G, Neilson, A, Javanbakht, M, Fielding, S, Cruickshank, M, Sharma, P, Fraser, C, Simpson, W,Brazzelli, M. Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Evidence Review Group report in support of the NICE STA Programme. University of Aberdeen: Health Services Research Unit; 2015

Sharma P, Boyers D, Scott N, Hernandez R, Fraser C, Cruickshank M et al.  The clinical and cost-effectiveness of open mesh repairs in adults presenting with a clinically diagnosed unilateral, primary inguinal hernia who are operated in an elective setting: systematic review and economic evaluation. Technology Assessment Report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2015.

Aucott L, Philip S, Avenell A, Sattar N, Wild S.  Patterns Of Weight Changes After Diagnosis In Patients With Type 2 Diabetes And Their Relationship With Metabolic and Cardiovascular Outcomes. Final grant report submitted to the Chief Scientist Office.  University of Aberdeen: 2014.

Adam E, McKee L.  Unscheduled Care and Support for Decision-Making: Consultancy Report. University of Aberdeen: Health Services Research Unit; 2014.

Azuara-Blanco A, Banister K, Boachie C, McMeekin P, Gray J, Burr J et al.  Comparative study of automated imaging technologies for the diagnosis of glaucoma (GATE study). Diagnostic accuracy, performance as triage tests, and cost-effectiveness. Final grant reported submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

Brazzelli M, Cruickshank M, Tassie E, Robertson C, McNamee P, Hernandez R et al.  Collagenase clostridium histolyticum for the treatment  of Dupuytren's contracture. Technology Assessment Report submitted to the National Institute for Health & Care Excellence.  University of Aberdeen: Health Services Research Unit; 2014.

Fielding S, Cummins E, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Aflibercept for treating diabetic macular oedema. Evidence Review Group Report in support of the NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E et al.  Systematic reviews and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Final grant report submitted to the NIHR HTA Programme.  University of Aberdeen: Health Services Research Unit; 2014.

Cummins E, Fielding S, Johnston R, Rothnie K, Stewart F, Lois N et al.  Aflibercept solution for injection for the treatment of wet age-related macular degeneration. Evidence Review Group report in support of NICE STA Programme.  University of Aberdeen: Health Services Research Unit; 2013.

Cummins E, Fielding S, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia. A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

Cummins E, Scott N, Rothnie K, Waugh N, Fraser C, Philip S et al.  Dapagliflozin for the treatment of type 2 diabetes: A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

The SCARLESS Study Group, [Ahmed A], [Krukowski Z], [McCormack K], [Cook JA], [McDonald A] et al.  Single port/incision laparoscopic surgery compared with standard 3 port laparoscopic surgery for appendicectomy - a randomised controlled trial. Final grant report submitted to the Chief Scientist Office.  University of Aberdeen: Health Services Research Unit; 2013.

West M, Baker R, Dawson J, Dixon-Woods M, Lilford R, Martin G et al.  Quality and safety in the NHS: evaluating progress, problems and promise. Final grant report submitted to the Department of Health.  Lancaster University; 2013.

Burr JM, Botello AP, Takwongi Y, Hernandez R, Vazquez-Montes M, Elders A et al.  Surveillance for ocular hypertension: evidence synthesis and economic evaluation. Final grant report submitted to NIHR HTA programme.  University of Aberdeen: Health Services Research Unit; 2012.

Cummins E, Fielding S, Cruickshank M, Fraser C, Lois N, Brazzelli M.  Ranibizumab for the treatment of choroidal neovascularisation associated with pathological myopia. A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2013.

Cummins E, Fielding S, Scott N, Rothnie K, Crowther M, Fraser C et al.  Eltrombopag for the treatment of chronic immune thrombocytopenic purpura: A Single Technology Appraisal. Evidence Review Group report in support of NICE STA programme.  University of Aberdeen: Health Services Research Unit; 2012.

Hoddinott P, Britten J, McInnes R, Craig L, Darwent K.  Significant others, situations and their influence on infant feeding. Final grant report submitted to NHS Scotland.  University of Aberdeen: Health Services Research Unit; 2012.